The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
- PMID: 10517669
- DOI: 10.1210/mend.13.10.0357
The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
Abstract
Estrogen receptors (ERs alpha and beta) enhance transcription in response to estrogens by binding to estrogen response elements (EREs) within target genes and utilizing transactivation functions (AF-1 and AF-2) to recruit p160 coactivator proteins. The ERs also enhance transcription in response to estrogens and antiestrogens by modulating the activity of the AP-1 protein complex. Here, we examine the role of AF-1 and AF-2 in ER action at AP-1 sites. Estrogen responses at AP-1 sites require the integrity of the ERalpha AF-1 and AF-2 activation surfaces and the complementary surfaces on the p160 coactivator GRIP1 (glucocorticoid receptor interacting protein 1), the NID/AF-1 region, and NR boxes. Thus, estrogen-liganded ERalpha utilizes the same protein-protein contacts to transactivate at EREs and AP-1 sites. In contrast, antiestrogen responses are strongly inhibited by ERalpha AF-1 and weakly inhibited by AF-2. Indeed, ERalpha truncations that lack AF-1 enhance AP-1 activity in the presence of antiestrogens, but not estrogens. This phenotype resembles ERbeta, which naturally lacks constitutive AF-1 activity. We conclude that the ERs enhance AP-1 responsive transcription by distinct mechanisms with different requirements for ER transactivation functions. We suggest that estrogen-liganded ER enhances AP-1 activity via interactions with p160s and speculate that antiestrogen-liganded ER enhances AP-1 activity via interactions with corepressors.
Similar articles
-
Estrogen receptor activation function 1 works by binding p160 coactivator proteins.Mol Endocrinol. 1998 Oct;12(10):1605-18. doi: 10.1210/mend.12.10.0185. Mol Endocrinol. 1998. PMID: 9773983
-
Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15161-6. doi: 10.1073/pnas.96.26.15161. Proc Natl Acad Sci U S A. 1999. PMID: 10611355 Free PMC article.
-
Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha.J Steroid Biochem Mol Biol. 2001 Aug;78(2):177-84. doi: 10.1016/s0960-0760(01)00083-8. J Steroid Biochem Mol Biol. 2001. PMID: 11566442
-
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. doi: 10.1016/s0960-0760(00)00104-7. J Steroid Biochem Mol Biol. 2000. PMID: 11162936 Review.
-
Estrogen receptor pathways to AP-1.J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):311-7. doi: 10.1016/s0960-0760(00)00108-4. J Steroid Biochem Mol Biol. 2000. PMID: 11162939 Review.
Cited by
-
Estrogen receptor β exon 3-deleted mouse: The importance of non-ERE pathways in ERβ signaling.Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5135-40. doi: 10.1073/pnas.1504944112. Epub 2015 Apr 6. Proc Natl Acad Sci U S A. 2015. PMID: 25848008 Free PMC article.
-
Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus.J Neurosci. 2002 Apr 1;22(7):2650-9. doi: 10.1523/JNEUROSCI.22-07-02650.2002. J Neurosci. 2002. PMID: 11923430 Free PMC article.
-
Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy.Mol Cell Endocrinol. 2012 Jan 30;348(2):430-9. doi: 10.1016/j.mce.2011.04.021. Epub 2011 Jun 1. Mol Cell Endocrinol. 2012. PMID: 21664237 Free PMC article. Review.
-
Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor.Int J Cancer. 2009 Apr 15;124(8):1841-51. doi: 10.1002/ijc.24133. Int J Cancer. 2009. PMID: 19117054 Free PMC article.
-
Pigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapy.Iran J Basic Med Sci. 2015 Sep;18(9):837-55. Iran J Basic Med Sci. 2015. PMID: 26523216 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous